BALTIMORE, June 24, 2022 (GLOBE NEWSWIRE) -- Protenus, the leading healthcare compliance analytics platform empowering healthcare to eliminate risk, received the highest overall performance score for its drug diversion surveillance solution in the recently published KLAS Drug Diversion Monitoring 2022 report. Clinical drug diversion creates huge risks for hospitals and health systems reputations and finances and the safety of their patients, workforces, and communities at-large. KLAS' report grades several vendors on their ability to consistently deliver guidance, analytics, and insight that helps their customers identify and prevent drug diversion.
Based on the report findings, Protenus also ranked the highest for delivery of new technology and proactive diversion monitoring capabilities as their solution assigns a suspicion score that identifies potential diversion events extremely well, leading the market in functionality and innovation. Customers described Protenus' support as proactive and appreciated the quarterly updates that incorporate customers' development suggestions.
Survey respondents rated Protenus above market average across the board on six customer experience pillars and see Protenus as a partner that regularly meets with customers and provides helpful implementation support. Along with proactive diversion insights that guide customer investigations, Protenus' solution delivers actionable analytics empowering customers to take a preventative approach to drug diversion.
Per one respondent commenting on Protenus solutions in the report, "We have readily available information that is actionable. If we want to be preventative, we need the information right away. We can't wait 24 hours to find out we were missing something or that something went wrong. The fact that we can monitor things in a live environment gives us the ability to see things as they happen. If we see the information later, that is not proactive. We can just visit the vendor's website, and with one click, we get a report of what is really going on. It takes a few minutes to resolve the case. What we have now compared to what we had before is a huge difference."
Protenus Co-Founder and CEO Nick Culbertson remarked, "Being proactive is key to mitigating the risks drug diversion poses. We're determined to help our customers quickly identify and address incidents as they happen using cohesive, actionable data in order to strengthen policy compliance and safety at their organizations."
About Protenus
Protenus harnesses the power of AI to provide healthcare organizations with scalable risk-reduction solutions that drive the safest patient outcomes while protecting the reputation of the organizations. We are committed to innovation, determined to reduce risk, and focused on supporting our community of employees, customers, and ultimately, patients. Empowering healthcare to eliminate risk is at the heart of all we do. Founded in 2014, Protenus is a three-time winner of Forbes' America's Best Startup Employers, is a Great Place to Work®-Certified company, and was named one of 2021 CBInsights Digital Health 150, one of The Best Places to Work in Healthcare by Modern Healthcare, and one of the Best Places to Work in Baltimore by the Baltimore Business Journal and the Baltimore Sun. Learn more at Protenus.com and follow us on Twitter @Protenus.
About KLAS
KLAS is a research and insights firm on a global mission to improve healthcare delivery by amplifying the provider's voice. Working with thousands of healthcare professionals and clinicians, KLAS gathers data and insights on software, services and medical equipment to deliver timely reports, trends and statistical overviews. The research directly represents the provider voice and acts as a catalyst for improving vendor performance. For more information on KLAS Research, visit www.klasresearch.com.
Media Contact
Amanda Rogers
Marketing Content Writer
amanda.rogers@protenus.com
Related Images
This content was issued through the press release distribution service at Newswire.com.
Attachment
